Theracryf Share Discussion Threads

[xxproinvestorxx] 28/5/2024 16:28

I think that presentation today was very positive, the second half of 2024, should be a good time for shareholders here.

[xxproinvestorxx] 28/5/2024 16:27

It was first mentioned in the presentation they issued for the chronos acquisition and cash raise. Also read the 'going concern' section of today's RNS. They mention they expect cash to last into Q4 25, and this is excluding the £0.9m raise, which extends this into 2026.

[jusjusjus] 28/5/2024 16:20

where/when did they say that?

[xxproinvestorxx] 28/5/2024 09:21

Terry,The company have cash till 2026, please tell me why a raise would be needed this autumn.

[clocktower] 28/5/2024 08:22

TD - What you have top ask yourself, is why were certain investors happy to put up money at 1p a short time ago, as they would have had the full knowledge of what was expected.

I am waiting to see the buying kick in later.

[terrydevlin1] 28/5/2024 07:52

Clock, there is no way this can go blue today, there is nothing positive in the update. I predict a 35% drop in share price today. You would have to be crazy to invest in this now, a share placing is inevitable in early autumn which would effectively end this share as an investment.

[clocktower] 28/5/2024 07:18

So the board still want to enrich themselves further by paying themselves bonuses for failure, by way of shares.

However they have given themselves time IF they receive the funds they say are due from Stalicla but like Juv, that is far from certain.

Over to the misleading Dr Huw with his presentation later today.

Shares do odd things so it may we end up blue today.

[terrydevlin1] 26/5/2024 12:34

I don’t know how anyone can think the results will be positive at all. Terrible 12 months here. No income, Juvenesense deal collapsed, Stalicla dispute, no new contracts signed, a share placing, money running out, next to no news on SFX-01 progressing. I think TCF may have a decent drug in SFX-01 buy they can’t afford to do any trials and can’t get anyone to trial it for them. Even if TCF get the $5.5m they hoped by the end of the year, where is the next income coming from? Stalicla payments clearly can’t be relied on. The end goal is already written here, another share placement which happens every 2 years is inevitable at some point. The shares will be diluted so much that there is no possibility of shareholders making any money here. There is no hope of TCF ever succeeding now. Don’t waste your time or money here.

[clocktower] 24/5/2024 16:01

Upwards and onwards again maybe markth123.

Seemed like a good time to buy. :-)

[markth126] 24/5/2024 14:56

Blue finish will be positive I feel

[clocktower] 24/5/2024 10:23

Seems to be falling in advance of the accounts, which everyone has been aware of for some time will be showing a substaintial loss but it seems to me the MM are lining up to drop it further, to see if they can get panicked sellers, and then there might be an opening to buy into an upward bounce.

So I might jump in again after the results.

It was pretty clear this was going to occur when there were buys of over 1.5 million at mid price earlier this week, and no tick up.

Good Luck for next week and good trading.

[clocktower] 22/5/2024 12:03

Well peterm10, it has kick started a bit of buying, and does seem like a positive start to more company activity and possibly investor news on a more regular basis.

I also note they do still mention Stalicla in the RNS, although a small note,it remains.

I guess it might take a few more buys for it to tick up though but a little surprised, that after the more positive research note, and this RNS that the buying has not continued.

[peterm10] 22/5/2024 11:30

Encouraging RNS and more proactive marketing. Hopefully the Erasmus team have some good news updates for us

[clocktower] 20/5/2024 16:17

Can buy at .74 now - tight spread.

[clocktower] 20/5/2024 14:41

Looks like a positve note, and published on the company website:




Reading this I would say the share is undervalued but having be bitten I am not yet ready to give it another go.

[peterm10] 20/5/2024 12:46

Long research note from research tree out today . No insight into the dispute with Stalicla

[lovewinshatelosses] 20/5/2024 10:19

Yeah, I am looking forward to next Tuesday in a macabre fashion myself.
The window of opportunity for fluffy words is getting smaller. What I am going to be interested in seeing is how long the current cash runway is, without that Stal payment. IMO, it is almost inconceivable that they would have diluted us to high heaven, as they did with that last raise, and bought so few shares from their own pocket as they did, if they had real confidence that it was going to be resolved in line with what we had been told to expect before.
But hey, sooner or later we will know without any uncertainty, for good, or more likely IMO, for bad.

[markth126] 19/5/2024 18:06

Come on Huw, we need an update on Stalicla the silence is deafening now. They either owe it or they don't? What's the situation, let the market know

[clocktower] 15/5/2024 15:19

That does not surprise me at this sort of level markth126 - out of interest what price are the bidding for 1 million, I ask because I just looked at the last few days trades, and the picture is mixed.

[markth126] 14/5/2024 13:30

As disappointing as it is down here, I can sell 1M shares which I've never seen before so someone wants them...!

[terrydevlin1] 10/5/2024 07:12

I agree with your comment Clock Tower. It is incredibly disappointing to have no new deals signed up for SFX-01 since the Stalicla deal. There seems so little news now about SFX-01 in the past 10 months.
The sad reality is that TCF cannot afford to do their own trials so they cannot do much to prove the drug is effective and it seems like they cannot get anyone to trial it for them.
The Stalicla deal is so huge to TCF that they have no option but to wait for Stalicla to decide what they will do and when they will do it. It is TCF’s only potential income stream and money is running out. It is over a quarter of a year since the dispute was issued and no news at all. It doesn’t feel like there will be any news any time soon either.

I feel for all investors who invested as a result of the Stalicla deal announcement in 2022. At that time with £10m in the bank, Juvenesense having a deal with SFX-01 and milestone payments of up to $160m with Stalicla it seemed like this share had great potential. I wish I never had stumbled on that RNS.

[clocktower] 08/5/2024 17:25

ABBYNAT - I have a number of trolls that follow me on most threads I post on. Some because I change my views when I am about to sell a stock or have sold it, as they have issues with me doing so.

Water off a ducks back. :-)

However, things do not look good here at present, as Stalicla are yet to pay up, and it is dragging, so one wonders if they will cough up. That said the information on their website has not changed but it is pretty poor that no update has been provided.

Crazy that they have not been able to strike any other deals for around 18 months with SFX-01.

If Staliclas paid up and they did anyother deal of that nature, then a huge bounce could be on the cards, and that is why I am watching still.

Maybe a bit of inside buying might show its head before a RNS, not that it did last time.